[1] |
中国中西医结合学会皮肤性病专业委员会色素病学组. 白癜风诊疗共识(2018版)[J]. 中华皮肤科杂志, 2018,51(4):247⁃250. doi: 10.3760/cma.j.issn.0412⁃4030.2018.04.001.
|
[2] |
Manga P, Elbuluk N, Orlow SJ. Recent advances in under⁃standing vitiligo[J]. F1000Res, 2016,5:F1000 Faculty Rev⁃2234. doi: 10.12688/f1000research.8976.1.
|
[3] |
Ezzedine K, Lim HW, Suzuki T, et al. Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference[J]. Pigment Cell Melanoma Res, 2012,25(3):E1⁃E13. doi: 10.1111/j.1755⁃148X.2012.00997.x.
|
[4] |
Vallerand IA, Lewinson RT, Parsons LM, et al. Vitiligo and major depressive disorder: a bidirectional population⁃based cohort study[J]. J Am Acad Dermatol, 2019,80(5):1371⁃1379. doi: 10.1016/j.jaad.2018.11.047.
|
[5] |
Sosa JJ, Currimbhoy SD, Ukoha U, et al. Confetti⁃like depigmentation: a potential sign of rapidly progressing vitiligo[J]. J Am Acad Dermatol, 2015,73(2):272⁃275. doi: 10.1016/j.jaad.2015.05.014.
|
[6] |
Marie J, Kovacs D, Pain C, et al. Inflammasome activation and vitiligo/nonsegmental vitiligo progression[J]. Br J Dermatol, 2014,170(4):816⁃823. doi: 10.1111/bjd.12691.
|
[7] |
Singh A, Kanwar AJ, Parsad D, et al. Randomized controlled study to evaluate the effectiveness of dexamethasone oral minipulse therapy versus oral minocycline in patients with active vitiligo vulgaris[J]. Indian J Dermatol Venereol Leprol, 2014,80(1):29⁃35. doi: 10.4103/0378⁃6323.125479.
|
[8] |
Aydin F, Senturk N, Sahin B, et al. A practical method for the estimation of vitiligo surface area: a comparison between the point counting and digital planimetry techniques[J]. Eur J Dermatol, 2007,17(1):30⁃32. doi: 10.1684/ejd.2007.0186.
|
[9] |
Zhang L, Chen S, Kang Y, et al. Association of clinical markers with disease progression in patients with vitiligo from China[J]. JAMA Dermatol, 2020,156(3):288⁃295. doi: 10.1001/jamadermatol.2019.4483.
|
[10] |
詹庆霞, 古昕平, 张峻岭. 各期白癜风共聚焦激光扫描显微镜下表现[J]. 继续医学教育, 2018,32(2):104⁃106. doi: 10.3969/j.issn.1004⁃6763.2018.02.053.
|
[11] |
刘涛. VIDA评分、临床特征、激光共聚焦扫描显微镜判定白癜风分期的研究[D]. 合肥: 安徽医科大学, 2015.
|
[12] |
许爱娥. 白癜风病期评估及干预[J]. 中华皮肤科杂志, 2017,50(10):765⁃767. doi: 10.3760/cma.j.issn.0412⁃4030.2017.09. 023.
|
[13] |
Mattoo SK, Handa S, Kaur I, et al. Psychiatric morbidity in vitiligo: prevalence and correlates in India[J]. J Eur Acad Dermatol Venereol, 2002,16(6):573⁃578. doi: 10.1046/j.1468⁃3083.2002.00590.x.
|
[14] |
Rodrigues M, Ezzedine K, Hamzavi I, et al. Current and emerging treatments for vitiligo[J]. J Am Acad Dermatol, 2017,77(1):17⁃29. doi: 10.1016/j.jaad.2016.11.010.
|
[15] |
Wang XX, Wang QQ, Wu JQ, et al. Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo[J]. Br J Dermatol, 2016,174(6):1318⁃1326. doi: 10.1111/bjd.14416.
|